Regulation of FGF23 Production in Osteocytes
- 9 February 2024
- journal article
- review article
- Published by Springer Nature in Current Osteoporosis Reports
- Vol. 22 (2) , 273-279
Abstract
Purpose of Review FGF23 is a bone-derived hormone working to reduce serum phosphate level. This review focuses on recent findings regarding regulatory mechanisms of FGF23 expression in osteocytes, FGF23 levels, and activities. Recent Findings Circulatory FGF23 levels reflecting FGF23 biological activities can be regulated by both FGF23 expression and posttranslational modification of FGF23 protein. O-linked glycosylation and phosphorylation of FGF23 protein as well as enzymes that can cleave FGF23 protein are involved in the posttranslational modification. However, precise mechanisms of FGF23 protein processing are not clear. Several extracellular factors have been shown to affect FGF23 levels in kidney injuries. Contribution of these factors may be different depending on the causes and stages of kidney injury. Summary FGF23 activities are regulated by complex mechanisms involving transcriptional and posttranslational modulations. There still remain several questions regarding the regulatory mechanisms of FGF23 expression and FGF23 processing.Keywords
This publication has 5 references indexed in Scilit:
- 1,25-Dihydroxyvitamin D3 regulates furin-mediated FGF23 cleavageJCI Insight, 2023
- Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasisJournal of Clinical Investigation, 2023
- Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney diseaseBone Research, 2021
- Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblastsKidney International, 2020
- Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidneyJournal of Clinical Investigation, 2020